BECOME A MEMBER

Get my in-depth research reports about the most interesting investments in the world

Please fill out the form below

Price: USD 49/year (recurring subscription; charging for the next 12 months can be cancelled at any time up to 15 days before your renewal date).

As an Annual Member you'll have access to:

  • 10 extensive research reports (PDF format) each year
  • Archive with all 25+ past research reports
  • Updates on previous research reports
  • Email alerts for reports and updates

Do you want to enjoy even more benefits, such as additional investment opportunities or priority booking of reader events and trips? Sign up for a Lifetime Membership.

Do you want to pay by cheque, cash or bank transfer? Would you like to purchase a gift voucher? Please send me a message.

Tax-deductible invoices can be downloaded from your account after sign-up.

 

Most recent

Latest reports (for Members only)

Bayer AG: similar to buying Volkswagen two years ago?

Bayer AG: similar to buying Volkswagen three years ago?

German blue chip Bayer is currently down and out. 2022 should bring a turnaround, though, similar to the one seen at Volkswagen.

A groundfloor opportunity in gaming and esports

A groundfloor opportunity in gaming and esports

This European entertainment champion is looking to turn itself into a global giant - and could gain 125% by mid-2022.

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Can coronavirus vaccine maker Novavax profit from the vast majority of unvaccinated people, and make vaccine sceptics fall in love with it?